This Experimental Drug Could Be a Game Changer for Pancreatic Cancer

Published on April 14, 2026

In a Phase III trial, Revolution Medicines' daraxonrasib almost doubled the survival length of people with advanced pancreatic cancer.

Continue reading on website
Other news

Meta Thinks Its Smart Glasses Could Stalk People in a ‘Thoughtful’ Way

April 14, 2026
Facial recognition but in, like, a good way.

Capcom’s Killing It Right Now

April 14, 2026
Pragmata and Resident Evil Requiem are the latest in a line of Capcom bangers